TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
Liver cancer, also known as hepatic cancer and primary hepatic cancer, is cancer that starts in the liver. Cancer which has spread from elsewhere to the liver, known as liver metastasis, is more common than that which starts in the liver. Symptoms of liver cancer may include a lump or pain in the right side below the rib cage, swelling of the abdomen, yellowish skin, easy bruising, weight loss, and weakness. The treatment of liver cancer patients is mainly determined by the organ involved, the tumor spread, the patient's general condition and age.
This report contains market size and forecasts of Liver Cancer Therapeutics in Global, including the following market information:
The global Liver Cancer Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Targeted Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liver Cancer Therapeutics include ArQule, Bayer, Bristol-Myers Squibb, Celsion, Eisai, Exelixis, Roche, Merck and Pfizer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Liver Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liver Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Liver Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)
Global Liver Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Liver Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)
Global Liver Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Liver Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
| Report Attributes | Report Details |
|---|---|
| Report Title | Liver Cancer Therapeutics Market, Global Outlook and Forecast 2022-2028 |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2021 |
| Forecast Year | 2029 |
| Number of Pages | 67 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
Frequently Asked Questions ?
